Notably, our findings reveal that caspase-2 roles in tumor suppression and hepatosteatosis control are separable and demonstrate that long-term inhibition of caspase-2 catalytic function disrupts the liver polyploid balance that augments liver pathophysiology and tumorigenesis. Here, CASP2 is linked to neoplasm.